标题:BTH-8, a novel poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor, causes DNA double-strand breaks and exhibits anticancer activities in vitro and in vivo
作者:Guo C.; Zhang F.; Wu X.; Yu X.; Wu X.; Shi D.; Wang L.
作者机构:[Guo, C] Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, 266042, China, Key Laboratory 更多
通讯作者:Guo, C(guochuanlong@qust.edu.cn)
通讯作者地址:[Guo, C] Department of Pharmacy, College of Chemical Eengineering, Qingdao University of Science and TechnologyChina;
来源:International Journal of Biological Macromolecules
出版年:2020
卷:150
页码:238-245
DOI:10.1016/j.ijbiomac.2020.02.069
关键词:Apoptosis; DNA double-strand breaks; HCC-1937; In vivo; PARP-1 inhibitor
摘要:Poly (ADP-ribose) polymerase (PARP) is a family of enzymes that play an important role in DNA repair. We designed 2-(2,3,6-tribromo-4,5-dimethoxybenzylidene) hydrazinecarbothioamide (BTH-8) as a novel human PARP (PARP-1) inhibitor with anticancer activities in vitro and in vivo. With an IC50 value of 79.79 ± 2.16 nM, BTH-8 caused DNA double-strand breaks, increased the foci quantitation of γ-H2AX and inhibited poly(ADP-ribose) (PAR) formation. BTH-8 could bind to PARP-1 with the target affinity [KD (equilibrium dissociation constant) value] of 1.372 μM. BTH-8 can inhibit the proliferation of a variety of tumor cells, especially BRCA-deficient cells (HCC-1937 and Capan-1). Further investigation showed that BTH-8 effectively induced a significant amount of G2/M cell cycle arrest and cell apoptosis in HCC-1937 cells. BTH-8 also exhibited antitumor activity in vivo, which was achieved by the inhibition of PARP-1. In sum, our study indicates that BTH-8 might be a novel suitable PARP-1 inhibitor to treat human breast cancer. © 2020 Elsevier B.V.
收录类别:SCOPUS
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079225182&doi=10.1016%2fj.ijbiomac.2020.02.069&partnerID=40&md5=ebba45d618c1a41a4b8e5036bc61b57b
TOP